Hims & Hers halts sale of Wegovy copycat pill following FDA crackdown on weight-loss drugs
Published on: Feb. 8, 2026, 7:36 a.m. | Source: Livemint
Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days after its launch, following FDA scrutiny. Here's all we know about the probe and US health department's moves.
